Dopamine D2 Receptors(D2R) Imaging in Prolactinomas
Status:
Not yet recruiting
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
To study the in vivo expression of dopamine D2 receptors in prolactinoma and the predictive
role of dopamine D2 receptors PET-MR imaging in the therapeutic effect of dopamine agonists.
Phase:
N/A
Details
Lead Sponsor:
Zhebao Wu
Collaborators:
Beijing Tiantan Hospital Chinese PLA General Hospital First Affiliated Hospital of Fujian Medical University First Affiliated Hospital of Wenzhou Medical University First Hospital of China Medical University Huashan Hospital Peking Union Medical College Hospital Xinqiao Hospital of Chongqing